SCHEMBL514284

SCHEMBL514284

[CH2]OC(=O)N(C)c1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.48
▸ HSD17B2 P37059 1/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.47
▸ TP53 P04637 3/20 0.46
▸ LIPE Q05469 3/20 0.44
▸ CES2 O00748 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 2/20 0.43
▸ TACR1 P25103 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.42
▸ POLQ O75417 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12220665 0.86 RXFP1 (0.54) HSD17B1HSD17B2RXFP1TP53LIPE
SCHEMBL12588888 0.82 NPSR1 (0.57) HSD17B1HSD17B2RXFP1TP53LIPE
SCHEMBL9357893 0.82 LMNA (0.57) HSD17B1HSD17B2RXFP1TP53LIPE
SCHEMBL28141847 0.81 TP53 (0.50) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL11174926 0.81 TACR1 (0.50) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL10943479 0.80 TP53 (0.49) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL8601016 0.80 TP53 (0.49) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL7535315 0.79 EGFR (0.50) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL11402034 0.77 POLQ (0.52) HSD17B1HSD17B2RXFP1TP53CES2
SCHEMBL28746553 0.77 MLYCD (0.54) HSD17B1HSD17B2RXFP1TP53CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 — — WO disclosed
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 — — WO disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 — — WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 — — EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 — — US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 HSD17B1 1752/4885HSD17B2 2249/4885RXFP1 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback